Enhabit, Inc. (NYSE:EHAB) Receives $8.75 Average PT from Brokerages

Enhabit, Inc. (NYSE:EHAB) has received an average recommendation of “Hold” from the six analysts that are presently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $8.75.

EHAB has been the subject of a number of research analyst reports. Leerink Partners restated a “market perform” rating and issued a $8.00 price target (down previously from $8.50) on shares of Enhabit in a research note on Tuesday, November 19th. Jefferies Financial Group upgraded shares of Enhabit from a “hold” rating to a “buy” rating and boosted their target price for the company from $8.25 to $9.50 in a research note on Monday, December 9th.

Insider Activity

In other news, Director Stuart M. Mcguigan purchased 15,000 shares of Enhabit stock in a transaction dated Tuesday, December 10th. The stock was bought at an average price of $8.81 per share, with a total value of $132,150.00. Following the completion of the acquisition, the director now owns 46,810 shares in the company, valued at $412,396.10. The trade was a 47.15 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jeffrey Bolton purchased 4,000 shares of Enhabit stock in a transaction dated Thursday, December 12th. The shares were purchased at an average cost of $8.69 per share, with a total value of $34,760.00. Following the acquisition, the director now owns 98,144 shares of the company’s stock, valued at approximately $852,871.36. This trade represents a 4.25 % increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 1.90% of the company’s stock.

Institutional Investors Weigh In On Enhabit

Several institutional investors have recently bought and sold shares of EHAB. FMR LLC raised its position in Enhabit by 138.4% in the third quarter. FMR LLC now owns 3,388 shares of the company’s stock worth $27,000 after acquiring an additional 1,967 shares in the last quarter. Quarry LP raised its position in Enhabit by 242.2% in the second quarter. Quarry LP now owns 3,703 shares of the company’s stock worth $33,000 after acquiring an additional 2,621 shares in the last quarter. Gladius Capital Management LP raised its position in Enhabit by 78.2% in the third quarter. Gladius Capital Management LP now owns 6,259 shares of the company’s stock worth $49,000 after acquiring an additional 2,747 shares in the last quarter. Stoneridge Investment Partners LLC bought a new stake in Enhabit in the third quarter worth about $81,000. Finally, Canada Pension Plan Investment Board bought a new stake in Enhabit in the second quarter worth about $93,000.

Enhabit Trading Down 2.6 %

EHAB opened at $7.60 on Wednesday. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.85. The firm’s 50 day moving average is $7.81 and its 200-day moving average is $8.15. The firm has a market capitalization of $382.16 million, a P/E ratio of -3.28 and a beta of 1.82. Enhabit has a 52-week low of $6.85 and a 52-week high of $11.74.

Enhabit (NYSE:EHAB) last issued its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). The company had revenue of $253.60 million during the quarter, compared to the consensus estimate of $261.69 million. Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. During the same quarter last year, the firm posted $0.03 EPS. Analysts expect that Enhabit will post 0.22 EPS for the current fiscal year.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.